Tony Michael Argenbright

Array ( [id] => 5464485 [patent_doc_number] => 20090324685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'MEDICAL DEVICE COATINGS CONTAINING CHARGED MATERIALS' [patent_app_type] => utility [patent_app_number] => 12/491434 [patent_app_country] => US [patent_app_date] => 2009-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6312 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324685.pdf [firstpage_image] =>[orig_patent_app_number] => 12491434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490061 [patent_doc_number] => 20110237495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'FUNCTIONAL METABOLOMICS COUPLED MICROFLUIDIC CHEMOTAXIS DEVICE AND IDENTIFICATION OF NOVEL CELL MEDIATORS' [patent_app_type] => utility [patent_app_number] => 12/993603 [patent_app_country] => US [patent_app_date] => 2009-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30399 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237495.pdf [firstpage_image] =>[orig_patent_app_number] => 12993603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561726 [patent_doc_number] => 20110275559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Long-Acting Y2 and/or Y4 Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 12/993015 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 43887 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275559.pdf [firstpage_image] =>[orig_patent_app_number] => 12993015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054676 [patent_doc_number] => 20110111036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'INTRACELLULAR ANTIBODY DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/991330 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10408 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111036.pdf [firstpage_image] =>[orig_patent_app_number] => 12991330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9869259 [patent_doc_number] => 08957032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Inhibition of gliadin peptides' [patent_app_type] => utility [patent_app_number] => 12/991658 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16514 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12991658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316443 [patent_doc_number] => 20090281041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'ANTIVIRAL CELL-PENETRATING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/436080 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11715 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281041.pdf [firstpage_image] =>[orig_patent_app_number] => 12436080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278452 [patent_doc_number] => 20120172318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/423975 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17497 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12423975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570260 [patent_doc_number] => 20090253638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Somatostatin Antagonists' [patent_app_type] => utility [patent_app_number] => 12/422625 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10932 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253638.pdf [firstpage_image] =>[orig_patent_app_number] => 12422625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9608203 [patent_doc_number] => 08785370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Reactive keratin protein formulations and methods of using for revitalizing hair' [patent_app_type] => utility [patent_app_number] => 12/421601 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 9279 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12421601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487469 [patent_doc_number] => 20110251135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'INHIBITORS OF PERITONEAL SEEDING OF CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 12/936185 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 40389 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251135.pdf [firstpage_image] =>[orig_patent_app_number] => 12936185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380284 [patent_doc_number] => 20090192123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of Thrombin and/or by elevated expression of Thrombin receptors' [patent_app_type] => utility [patent_app_number] => 12/418001 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5140 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192123.pdf [firstpage_image] =>[orig_patent_app_number] => 12418001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496335 [patent_doc_number] => 20090264363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Leucine-Rich Peptide Compositions and Methods for Isolation' [patent_app_type] => utility [patent_app_number] => 12/411772 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5540 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264363.pdf [firstpage_image] =>[orig_patent_app_number] => 12411772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6372685 [patent_doc_number] => 20100080797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'THERAPY PROCEDURE FOR DRUG DELIVERY FOR TRIGEMINAL PAIN' [patent_app_type] => utility [patent_app_number] => 12/409413 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19505 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080797.pdf [firstpage_image] =>[orig_patent_app_number] => 12409413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490829 [patent_doc_number] => 20090291900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'METHODS FOR TREATMENT OF HEADACHES BY ADMINISTRATION OF OXYTOCIN' [patent_app_type] => utility [patent_app_number] => 12/409419 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17233 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291900.pdf [firstpage_image] =>[orig_patent_app_number] => 12409419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392269 [patent_doc_number] => 20100303842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'PEPTIDE ANALOGUES' [patent_app_type] => utility [patent_app_number] => 12/406022 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 41997 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303842.pdf [firstpage_image] =>[orig_patent_app_number] => 12406022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136173 [patent_doc_number] => 20110009313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'POLYETHYLENE GLYCOLATED LACTOFERRIN COMPLEX AND METHOD OF PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/921470 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7270 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009313.pdf [firstpage_image] =>[orig_patent_app_number] => 12921470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664610 [patent_doc_number] => 08378071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/402401 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 17366 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12402401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095427 [patent_doc_number] => 20110002969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING METALLOPROTEINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/920241 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16927 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002969.pdf [firstpage_image] =>[orig_patent_app_number] => 12920241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560190 [patent_doc_number] => 08334253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Cosmetic and dermatological formulations of MNTF peptides' [patent_app_type] => utility [patent_app_number] => 12/391243 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13395 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12391243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538782 [patent_doc_number] => 20090220587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands' [patent_app_type] => utility [patent_app_number] => 12/379096 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9048 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220587.pdf [firstpage_image] =>[orig_patent_app_number] => 12379096 [rel_patent_id] =>[rel_patent_doc_number] =>)